{"id": "1374997045937856512", "creation": 1616659816.0, "user_id": "1195310926976765952", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "New in @TheLancetInfDis&gt; Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit #vaccine (ZF2001) against #COVID19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials https://t.co/Ul4h5wMhN5", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}